Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study Patients with ≥1 prior line of therapy were ...

Medicare covers intravenous (IV) infusion therapy when a doctor prescribes it as medically necessary. Original Medicare Part A typically covers the costs if you have an IV infusion during an inpatient ...

Lidocaine infusion matches nerve block in terms of opioid use at 24 hours after knee replacement surgery, a study finds.

After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...

People with multiple myeloma who once spent hours connected to an intravenous drip for daratumumab can now receive the same ...

In cancer care, every hour a patient spends getting treatment is an hour away from the rest of their life. It could mean another afternoon in an infusion chair instead of at home. Another childcare ...

Newborns, particularly premature infants, are highly vulnerable during intravenous infusion treatments due to their low immunity, inability to express discomfort, and fragile veins. Chemical ...

While Eli Lilly’s investigational monoclonal antibody drug, bamlanivimab, just received FDA emergency approval to treat mild coronavirus patients, top officials voiced concerns over its challenging IV ...

The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, ...

The medical world is changing, and prioritizing patient comfort, experience and care is one of the main transformations ...